HSP90AA1 and pancreatic adenocarcinoma: For DSS, high expression of HSP90AA1 in BLCA, LIHC, LUAD, MESO and PAAD had unfavorable prognosis but KIRC patients with higher expression of HSP90AA1 indicated better prognosis (Figure 5C).